30,000 MG01 + 10,000 T517: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving 30,000 MG01 + 10,000 T517

• Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
  NCT04891237 · Phase: Phase 3 · Ages: 12 Years to 65 Years · Sex: All (male and female) · 32 locations

Common questions

How many recruiting trials involve 30,000 MG01 + 10,000 T517?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.